ELTX
#4231
Elicio Therapeutics, Inc. - Common Stock
2.9 7 USD
-0.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.50%
Monthly Change
-26.85%
6 month change
-62.02%
Year Change
-70.30%
Previous Close
3.1 1
Open
2.9 4
Low
2.9 4
High
3.0 4
Volume
135
Financials
- Market Capitalization 56.69 M
- Employee 33
- Founded 2011
- CEO N/A
- Website www.elicio.com
- Headquarter Delaware, United States
- FIGI BBG00444GM02
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.53
Price to sales ratio
14.98 K
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4228 |  EDSA Edesa Biotech, Inc. - Common Shares | 6.70 USD | -0.59% | -9.34% | +12.79% | +207.34% | 59.58 M USD | ||
| 4229 |  TCRX TScan Therapeutics, Inc. - Common Stock | 0.92 USD | -1.08% | -21.37% | -2.13% | -48.60% | 56.19 M USD | ||
| 4236 |  CNTX Context Therapeutics Inc. - Common Stock | 0.62 USD | 0.00% | 0.00% | -11.43% | -19.48% | 56.97 M USD | ||
| 4247 |  INMB INmune Bio Inc. - Common stock | 2.10 USD | +3.96% | +20.00% | +62.79% | +1.94% | 55.83 M USD |
Frequently asked questions about Elicio Therapeutics, Inc. - Common Stock
What is the Elicio Therapeutics, Inc. - Common Stock stock price today?
The current price of Elicio Therapeutics, Inc. - Common Stock (ELTX) is 2.9699999999999998. Over the past 24 hours, the stock has changed by -4.50%. Follow the ELTX chart for real-time price dynamics.
What is the stock ticker of Elicio Therapeutics, Inc. - Common Stock?
Elicio Therapeutics, Inc. - Common Stock trades under the ticker ELTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Elicio Therapeutics, Inc. - Common Stock stock going up?
ELTX has changed by -11.87% over the last week, -26.85% over the last month, and -70.30% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Elicio Therapeutics, Inc. - Common Stock net income for the last quarter?
Elicio Therapeutics, Inc. - Common Stock reported net income of -11.82 M for the last quarter. The previous quarter showed -7.72 M, which means net income changed by -53.19%.
How many employees does Elicio Therapeutics, Inc. - Common Stock have?
As of the latest available data, Elicio Therapeutics, Inc. - Common Stock has 33 employees. Workforce size can provide additional context about the company's scale and operations.
What is Elicio Therapeutics, Inc. - Common Stock EBITDA?
Elicio Therapeutics, Inc. - Common Stock EBITDA is -10.47 M, and its EBITDA margin is -80.58 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Elicio Therapeutics, Inc. - Common Stock stock?
You can buy Elicio Therapeutics, Inc. - Common Stock (ELTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Elicio Therapeutics, Inc. - Common Stock stock?
Investing in Elicio Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ELTX chart and related analysis on metatrader.com as part of your research.